Week Ahead: 2 Undervalued Stocks Report Earnings
Both wide-moat Monsanto and no-moat Bed, Bath and Beyond are trading below Morningstar's fair value estimates ahead of their earnings reports. Plus, Fed minutes due on Wednesday.
For Morningstar, I'm Jeremy Glaser. Welcome to The Week Ahead, our quick take on what investors should have on their radar screens for the week starting April 4.
After a busy data week, it will be a bit calmer as we kick off the second-quarter in earnest.
Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.